Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

IRCCS Azienda Ospedaliero-Universitaria di Bologna at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

IRCCS Azienda Ospedaliero-Universitaria di Bologna brings 11 presentations to ASH 2026 in New Orleans. Its program centres on myeloproliferative neoplasms, myeloma and acute leukemia. It includes a score predicting thrombosis in myelofibrosis and dose optimization for the menin inhibitor enzomenib.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
University of Bologna teaching hospital, the Sant'Orsola Polyclinic, home of the Seràgnoli Institute of Hematology.
Symposium
Fri Dec 11
7:00am–10:00am
Anti-BCMA Bispecific Antibodies in Multiple Myeloma: From Biology to Real-World Implementation
Bispecific antibodies targeting B-cell maturation antigen in myeloma, from mechanism and resistance to trial data, outpatient dosing, and infection prevention.
Myeloma · New drugs
Talk
Sat Dec 12
9:30am–10:45am
Preventing Progression and Overcoming Resistance in MPNs
Moving myeloproliferative neoplasm care toward earlier disease-modifying therapy and molecular monitoring, and handling resistance to Janus kinase inhibitors.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at IRCCS Azienda Ospedaliero-Universitaria di Bologna

Tell us what you sell and we’ll find the people at IRCCS Azienda Ospedaliero-Universitaria di Bologna most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction